The largest community of pharma leaders

Dr. Jessica Fan Fleet-Green Joins Daiya Healthcare as the Chief Medical Officer

BELLEVUE, Wash.–()–Jessica Van Fleet-Green joins the leadership team of Daiya Healthcare. Reporting to Founder and CEO, Dr. Bhupinder Walia, she will lead a growing team of post-acute and long-term care clinicians in multiple centers across the Western United States.

Dr. Van Fleet-Green is an experienced family physician, medical director, and physician executive. She is a fellow for the American Academy of Family Physicians and Certified Medical Director with the Society for Post-Acute and Long-Term Care (PALTC) and serves on the board for the Washington State Society of PALTC Medicine. Her work in the COVID-19 crisis related to Personal Protective Equipment, drop teams to support public health efforts, and mass testing has been featured in nationwide broadcasted webinars, public radio, Amazon, and the Tacoma News Tribune.

Since 2017, Dr. Van Fleet-Green has been serving as the Chief Medical Officer for Physicians of Southwest Washington, a population health company with demonstrated excellence in risk-based models. In addition to her primary role with leadership of the organization, she also served as a clinical officer for MultiCare Health Systems working on post-acute strategy and quality metric development. Dr. Van Fleet-Green’s interests include quality improvement, systems-based practice, and policy and advocacy work for Post-Acute and Long-Term Care. She is well versed in Advanced Alternative Payment Models and Value Based Healthcare. Dr. Van Fleet-Green has demonstrated rapport with her clinician, administrator, and nursing colleagues alike and prioritizes fostering a collaborative and interdisciplinary process to create a holistic, patient-centered experience.

“Much has changed since COVID-19. With PALTC as a hot spot of this unprecedented pandemic, the call to serve these patients and the facilities which care for them has never been greater. I look forward my new role at Daiya Healthcare and am honored to work for an organization with a deep commitment to direct patient care. I so appreciate the opportunity to have worked with Physicians of Southwest Washington over the last several years and will be forever grateful for their confidence in me as a leader and physician.”

Dr. Van Fleet-Green attended the University of Washington where she received a Bachelor of Science degree in Rehabilitation Medicine, Prosthetics-Orthotics, and went on to attend medical school at the University of Washington School of Medicine. She trained in Family Medicine at Providence St. Peter Hospital in Olympia as part of the University of Washington WWAMI Residency Program and remained on faculty teaching residents until 2019. She is an avid distance runner and equestrian and lives in Washington State with her spouse and two children.

Daiya Healthcare is a physician owned multi-specialty provider group offering unparalleled services in post-acute and long-term care centers. Based in Bellevue, Washington, Daiya Healthcare is the nation’s leader in post-acute and long-term care medicine. They currently serve in over 60 centers throughout Washington, Oregon, Idaho, Hawaii and California. Daiya Healthcare is based on a core value system of Integrity, Compassion, Diversity and Accountability, which is essential to providing an integrative care model to the communities and partners they serve. To learn more about Daiya Healthcare, please visit the company website at www.daiyahealthcare.com

Source

Recent Articles

Javelin Biotech Aims to Develop Industry-Leading “Organ-on-a-Chip” Predictive Pharmacokinetics Platform in Collaboration with Pfizer Inc.

WOBURN, Mass.--(BUSINESS WIRE)--Javelin Biotech today announces a 3-year collaboration with Pfizer...

TriSalus Life Sciences Lays Out Therapeutic Strategy Upon Acquisition of First Therapeutic Candidate

DENVER & CHICAGO--(BUSINESS WIRE)-- #TollLikeReceptor--TriSalus Life Sciences announces its therapeutic clinical...

Cortexyme Announces GAIN Trial of Atuzaginstat in Alzheimer’s Disease Has Exceeded Study Enrollment Target of 570 Patients

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX) today announced that...

VBI Vaccines to Present at Upcoming Scientific Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $VBIV--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage...

Anokion Announces FDA Clearance of IND Application for ANK-700 for the Treatment of Multiple Sclerosis

CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--Anokion Announces FDA Clearance of IND...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.